Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 3.05 is 48% below its 5-year average of 5.86, near the low end of its 5-year range (0.00–31.48).
As of the fiscal period ended Tuesday, June 30, 2026. 30.13% below its 12-month average of 4.37.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 3.05.
CURRENT RATIO
3.05
CURRENT RATIO AVG TTM
4.37
CURRENT RATIO AVG 3Y
5.44
CURRENT RATIO AVG 5Y
5.86
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-30.13%
CURRENT VS 3Y AVG
-43.82%
CURRENT VS 5Y AVG
-47.90%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
-18.55%
vs the sector median at left
Market Cap
$637.78M
Current Ratio
16.82
TTM Avg
9.46
3Y Avg
14.12
5Y Avg
14.05
Market Cap
$629.87M
Current Ratio
5.17
TTM Avg
4.10
3Y Avg
4.28
5Y Avg
7.57
Market Cap
$656.15M
Current Ratio
1.36
TTM Avg
1.59
3Y Avg
1.59
5Y Avg
1.59
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Prime Medicine, Inc. (PRME) | $636.68M | 3.05 | 4.37 | 5.44 | 5.86 |
| Aura Biosciences, Inc. (AURA)vs › | $637.78M | 16.82 | 9.46 | 14.12 | 14.05 |
| OmniAb, Inc. (OABI)vs › | $638.60M | 4.80 | 4.27 | 4.36 | 3.29 |
| Zevra Therapeutics, Inc. (ZVRA)vs › | $629.87M | 5.17 | 4.10 | 4.28 | 7.57 |
| SOPHiA GENETICS S.A. (SOPH)vs › | $628.52M | 2.69 | 2.83 | 4.29 | 5.35 |
| Climb Bio, Inc. (CLYM)vs › | $619.34M | 31.45 | 23.29 | 26.88 | 23.21 |
| Starling Oncology, Inc. (STLN)vs › | $656.15M | 1.36 | 1.59 | 1.59 | 1.59 |
| MiMedx Group, Inc. (MDXG)vs › | $668.98M | 5.33 | 4.27 | 3.79 | 3.57 |
| Annexon, Inc. (ANNX)vs › | $668.22M | 5.53 | 8.02 | 10.47 | 14.43 |
| 4D Molecular Therapeutics, Inc. (FDMT)vs › | $670.80M | 8.03 | 12.16 | 13.50 | 14.42 |
Current Ratio
3.05
Quick Ratio
3.05
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 3.05 |
| 2026-03-31 | 3.80 |
| 2025-12-31 | 4.84 |
| 2025-09-30 | 6.61 |
| 2025-06-30 | 3.56 |
| 2025-03-31 | 4.78 |
| 2024-12-31 | 5.58 |
| 2024-09-30 | 6.50 |
| 2024-06-30 | 8.23 |
| 2024-03-31 | 8.91 |
| 2023-12-31 | 2.53 |
| 2023-09-30 | 4.69 |
| 2023-06-30 | 7.61 |
| 2023-03-31 | 10.62 |
| 2022-12-31 | 11.10 |
| 2022-09-30 | 6.70 |
| 2022-06-30 | 7.62 |
| 2022-03-31 | 16.44 |
| 2021-12-31 | 4.67 |
| 2021-09-30 | 31.48 |
| 2021-06-30 | 0.00 |
| 2021-03-31 | 0.00 |
| 2020-12-31 | 0.00 |
| 2019-12-31 | 0.00 |
